Fennec Net Tangible Assets from 2010 to 2024
| FENC Stock | USD 6.78 0.07 1.02% |
Net Tangible Assets | First Reported 2000-06-30 | Previous Quarter -7.3 M | Current Value -9.7 M | Quarterly Volatility 11.1 M |
Check Fennec Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fennec main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 436.6 K or Interest Expense of 3.6 M, as well as many exotic indicators such as Price To Sales Ratio of 13.09, Dividend Yield of 0.0 or Days Sales Outstanding of 140. Fennec financial statements analysis is a perfect complement when working with Fennec Pharmaceuticals Valuation or Volatility modules.
Fennec | Net Tangible Assets |
Latest Fennec Pharmaceuticals' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Fennec Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Fennec Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fennec Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Fennec Net Tangible Assets Regression Statistics
| Arithmetic Mean | 6,454,868 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 176.78 | |
| Mean Deviation | 9,668,355 | |
| Median | 548,000 | |
| Standard Deviation | 11,411,194 | |
| Sample Variance | 130.2T | |
| Range | 32M | |
| R-Value | 0.22 | |
| Mean Square Error | 133.2T | |
| R-Squared | 0.05 | |
| Significance | 0.42 | |
| Slope | 573,084 | |
| Total Sum of Squares | 1823T |
Fennec Net Tangible Assets History
About Fennec Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fennec Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Fennec Pharmaceuticals investors use historical funamental indicators, such as Fennec Pharmaceuticals's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Fennec Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Fennec Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fennec Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fennec Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fennec Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | -3 M | -2.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out the analysis of Fennec Pharmaceuticals Correlation against competitors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 1.684 | Quarterly Revenue Growth 14.132 | Return On Assets 0.0857 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.